90% of males in Russia suffer from some degree of erectile dysfunction according to PRAVDA, the country's national news organization
25-54 years: 44.71% male 31,220,990
55-64 years: 14.44% male 8,849,707
65 years and over: 14.28% male 6,352,557 (2017 est.)
Creative Medical Technology Holdings Announces Caverstem Contract For Russia
7/19/18, 8:15 AM
PHOENIX, July 19, 2018 /PRNewswire/ -- Creative Medical Technology Holdings Inc. (OTCQB ticker symbol CELZ) announced today that its subsidiary Caverstem International LLC has signed an exclusive contract with Promo Med Russia for the commercialization of its CaverStemTM technology.
As previously disclosed, Creative Medical Technology Holdings, Inc. formed the subsidiary CaverStem International LLC for the purpose of commercializing its erectile dysfunction technology to international physicians.
Professor Dimitri Pushkar MD, Director of Urology at Moscow University, Urologist General of Russia and a decades long colleague of Dr. Alex Gershman was key in the fast paced movement of this agreement and moreover in establishing the practice of the CaverStemTM procedure in Russia.
"Upon meeting with Dr. Gershman and the CaverStemTM team at the American Urological Association conference in May, I became more familiar with the CaverStemTM technology and quickly identified it as a valuable treatment for the escalating erectile dysfunction problems in Russia. As physicians it is our responsibility to seek out and develop advanced technologies in medicine to improve the quality of our patients lives," said Dr. Pushkar.
"We are excited and appreciative that a physician of Dr. Pushkar's reputation is involved in expanding our technology to the international medical community. We also wish to thank Dr. Gershman, as his decades long relationships and stellar international reputation were instrumental in furthering our expansion of CaverStemTM," said Timothy Warbington, CEO of Creative Medical Technology Holdings.
Because of our mutual desire for a more immediate implementation of CaverStemTM , CELZ VP of Sales, Gary Mells is currently in Russia meeting with multiple urologists and officials. We are beginning the applications and other regulatory paperwork required by the United States and Russia to import our technology," Mr. Warbington further said.
According to The Pravda Report, up to 90% of adult males in Russia suffer from some degree of erectile dysfunction.
No wonder why the stock is UP somewhere in the 15% range today
25-54 years: 44.71% male 31,220,990
55-64 years: 14.44% male 8,849,707
65 years and over: 14.28% male 6,352,557 (2017 est.)
Creative Medical Technology Holdings Announces Caverstem Contract For Russia
7/19/18, 8:15 AM
PHOENIX, July 19, 2018 /PRNewswire/ -- Creative Medical Technology Holdings Inc. (OTCQB ticker symbol CELZ) announced today that its subsidiary Caverstem International LLC has signed an exclusive contract with Promo Med Russia for the commercialization of its CaverStemTM technology.
As previously disclosed, Creative Medical Technology Holdings, Inc. formed the subsidiary CaverStem International LLC for the purpose of commercializing its erectile dysfunction technology to international physicians.
Professor Dimitri Pushkar MD, Director of Urology at Moscow University, Urologist General of Russia and a decades long colleague of Dr. Alex Gershman was key in the fast paced movement of this agreement and moreover in establishing the practice of the CaverStemTM procedure in Russia.
"Upon meeting with Dr. Gershman and the CaverStemTM team at the American Urological Association conference in May, I became more familiar with the CaverStemTM technology and quickly identified it as a valuable treatment for the escalating erectile dysfunction problems in Russia. As physicians it is our responsibility to seek out and develop advanced technologies in medicine to improve the quality of our patients lives," said Dr. Pushkar.
"We are excited and appreciative that a physician of Dr. Pushkar's reputation is involved in expanding our technology to the international medical community. We also wish to thank Dr. Gershman, as his decades long relationships and stellar international reputation were instrumental in furthering our expansion of CaverStemTM," said Timothy Warbington, CEO of Creative Medical Technology Holdings.
Because of our mutual desire for a more immediate implementation of CaverStemTM , CELZ VP of Sales, Gary Mells is currently in Russia meeting with multiple urologists and officials. We are beginning the applications and other regulatory paperwork required by the United States and Russia to import our technology," Mr. Warbington further said.
According to The Pravda Report, up to 90% of adult males in Russia suffer from some degree of erectile dysfunction.
No wonder why the stock is UP somewhere in the 15% range today
Creative Medical Technology Holdings Inc (CELZ) Stock Research Links
Louis Pasteur -- chance favours only the prepared mind.
Lecture, University of Lille (7 December 1854)
Lecture, University of Lille (7 December 1854)
